Flagship Pioneering
Sr. Director, Clinical Operations
$213K–$280K
Somerville, MA USA +1 · Director · Full-time · Posted Sep 24, 2026
- Location
- Somerville, MA USA
Metaphore Biotechnologies, Inc. - Experience
- 10+ years of progressive clinical operations experience.
- Education
- BS/MS/PhD degree in a scientific, healthcare, or related discipline; an advanced degree is preferred.
About the job
Leads hands-on clinical operations planning and execution for Metaphore’s first-in-human program, with primary responsibility for Phase 1 readiness, global study start-up, and delivery.
What you'll do
- Plan and execute early clinical studies, including study timelines, budgets, forecasts, risks, and operational documentation.
- Select and oversee CROs, vendors, and clinical sites; manage study start-up and execution across the U.S., Europe, Australia, and other regions.
- Establish fit-for-purpose clinical operations processes and ensure studies meet protocol, ICH-GCP, regulatory, quality, and inspection-readiness requirements.
What they ask for
- 10+ years of progressive clinical operations experience in biotechnology or pharmaceutical industry.
- Direct experience leading first-in-human or Phase 1 studies from operational planning through site activation and ongoing execution.
- Experience managing study budgets, vendor contracts, scopes of work, change orders, timelines, and forecasts.
- BS/MS/PhD in a scientific, healthcare, or related discipline; strong knowledge of ICH-GCP and FDA, EU, and other ex-U.S. clinical trial requirements.
Nice to have
- Advanced degree; experience in both biotechnology and pharmaceutical company environments.
- Early-phase study experience in Australia, China, antibody or biologic programs, or specialized biomarker and bioanalytical strategies.
Pay
$213,000 - $280,000 USD base salary
Tools
AI/ML, CROs, ICH-GCP, TMF, FDA, EU
AI focus
No AI-related job duties; the posting notes that applicant data may be reviewed using AI-assisted screening tools.
Model-written summary · the original posting is authoritative